Australian Household Spending Dips in December as RBA Tightens Policy 
AI is driving down the price of knowledge – universities have to rethink what they offer 
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Parents abused by their children often suffer in silence – specialist therapy is helping them find a voice 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Youth are charting new freshwater futures by learning from the water on the water 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Yes, government influences wages – but not just in the way you might think 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
The pandemic is still disrupting young people’s careers 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
BioNTech SE, a Mainz-based German biotech firm, confronts a homegrown lawsuit seeking compensation for purported COVID-19 vaccine side effects. The initial case, scheduled for court on June 12, is expected to precipitate nationwide litigation.
BioNTech is set to attend the first court hearing on Monday, June 12. It will go to court to defend itself from the first case filed by a German woman who allegedly suffered from side effects after receiving her COVID-19 jab. She is seeking damages, and more cases are expected to be filed across the country after this.
According to Reuters, the plaintiff is suing the biotech firm and asking for at least €150,000 or about $161,500 in damages. The regional court in Hamburg said that in her lawsuit, the woman said the amount is for bodily harm and other material damages that were not specified.
For this case, she is being represented by Rogert & Ulbrich law firm. She claimed that after the jab, she suffered from pains in the upper part of her body, developed a sleeping disorder, fatigue, and swollen extremities. Her lawyer, Tobias Ulbrich, told the publication that will challenge the assessment made by European Union regulators and the vaccine assessment bodies in Germany that said the BioNTech vaccine has positive benefits.
In any case, it was mentioned that under German pharmaceutical law, drug or vaccine makers are only liable to give compensation for side effects if medical science shows that their products bear incorrect information or have caused disproportionate harm commensurate to their benefits.
With this, BioNTech believes that after a careful review and consideration of the case, it concluded that the lawsuit holds no merit. It also noted that the same vaccine was already received by some 1.5 billion people around the world, including more than 64 million Germans.
Meanwhile, despite BioNTech’s statements, Financial Times reported that the law firm representing the woman insisted that the burden of proof and the possible compensation is lower in Germany. Thus, it is confident that their case against BioNTech is strong.
Photo: Mat Napo/Unsplash
